The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -13.12 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -2.73 — no flag raisedOK
- Earnings quality 82/100 — accruals in line with cashOK
Leadership changes
From NeuroPace Inc's own filings, the day they're filed.
- Rebecca Kuhn · Chief Financial Officer · departureeff. 2025-06-20
- Michael Favet · Chief Executive Officer · departureeff. 2023-07-10
- Joel Becker · Chief Executive Officer · appointmenteff. 2023-06-28
Latest filings
- 8-K · Company announcement2026-06-08
- 10-Q · Quarterly report2026-05-12
- 8-K · Company announcement2026-05-12
- DEF 14A · Annual proxy (pay & governance)2026-04-21
- 8-K · Company announcement2026-03-03
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about NeuroPace Inc, every answer cited🔒
- The Intelligence Brief — added when NeuroPace Inc's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.